Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
---|---|---|---|---|---|
Lisen Axell MS | None | None | None | None | 04/13/2022 |
Marian Birkeland PhD | None | None | None | None | 03/08/2022 |
Carol Burke MD | Emtora biosciences Freenome inc Janssen Pharmaceutica Products, LP |
freenome inc SLA pharma |
None | None | 12/24/2021 |
Lee-May Chen MD | AstraZeneca Pharmaceuticals LP Genentech, Inc. GlaxoSmithKline |
None | None | None | 03/20/2022 |
Daniel Chung MD | Immunovia Iterative Scopes Janssen Pharmaceutica Products, LP |
Guardant | None | None | 03/10/2022 |
Katherine Clayback MS,CGC | None | None | None | None | 04/22/2022 |
Eileen Cucinotta | None | None | None | None | 06/13/2022 |
Susan Dallas | None | None | None | None | 01/03/2022 |
Susan Darlow PhD | None | None | None | None | 03/11/2022 |
Mary Dwyer MS | None | None | None | None | 06/20/2022 |
Seth Felder MD | None | None | None | None | 05/13/2022 |
Francis Giardiello MBA,MD | None | None | Steinberg Gastroenterology Board Review Course | None | 11/23/2021 |
William Grady MD | Diacarta Janssen Pharmaceutica Products, LP Lucid Technologies Nephron Tempus |
Freenome Guardant Health SEngine |
WebMD | None | 05/31/2022 |
Kristina Gregory OCN,MSN,RN | None | None | None | None | 03/27/2022 |
Samir Gupta MD | Epigenomics Freenome |
Cellmax Guardant |
None | None | 02/06/2022 |
Michael Hall MS,MD | Caris Life Sciences Invitae Myriad Genetic Laboratories, Inc. |
GRAIL | None | None | 12/13/2021 |
Heather Hampel LGC,MS | National Cancer Institute | Genome Medical GI OnDemand Invitae Genetics Promega |
None | None | 10/05/2021 |
Rachel Hodan MS,CGC | None | None | None | None | 06/06/2022 |
Gregory Idos MS,MD | None | None | None | None | 11/19/2021 |
Bryson Katona MD,PhD | Ambry Freenome GeneDx Guardant Immunovia Invitae Janssen Pharmaceutica Products, LP Universal Diagnostics |
None | None | None | 06/13/2022 |
Moh'D Khushman MD | AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Ipsen |
Bayer HealthCare Taiho Parmaceuticals Co., Ltd. |
Pfizer Inc. | None | 02/25/2022 |
Laura Lamps MD | None | Ibex Medical Analytics Scientific Symposiums International |
None | United States and Canadian Academy of Pathology | 05/19/2022 |
Xavier Llor PhD,MD | None | None | None | None | 03/25/2022 |
Patrick Lynch MD,JD | SLA Pharma | SLA Pharma | None | None | 11/26/2021 |
Arnold Markowitz MD | None | None | None | None | 05/11/2022 |
Mariana Niell-Swiller MS | None | None | None | None | 07/01/2022 |
Sara Pirzadeh-Miller MS | None | None | None | None | 04/18/2022 |
Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 06/21/2022 |
Jewel Samadder MD | Cancer Prevention Pharmaceuticals Janssen Pharmaceutica Products, LP |
Cancer Prevention Pharmaceuticals Janssen Pharmaceutica Products, LP Recursion Pharmaceuticals |
None | None | 12/05/2021 |
David Shibata MD,FACS,FASCRS | None | None | None | None | 02/09/2022 |
Peter Stanich MD | Emtora Biosciences Freenome Gaurdant Invitae Corp. Janssen Pharmaceutica Products, LP Pfizer Inc. PTEN Research foundation |
None | UpToDate, Inc. | Collaborative Group of the Americas on Inherited Gastrointestinal Cancers | 06/26/2022 |
Benjamin Swanson PhD,MD | None | Cogen Bioscience | None | Cogen Bioscience | 03/29/2022 |
Brittany Szymaniak PhD,CGC | None | "Technology-enhanced AcceleRation of Germline Evaluation for Therapy - The TARGET study" which has been funded by the Prostate Cancer Foundation. | UroGPO | None | 03/31/2022 |
Jennifer Weiss MD,MS | Exact Sciences | None | American College of Physicians Medscape |
None | 02/09/2022 |
Jeanna Welborn MD | None | None | None | None | 04/29/2022 |
Georgia Wiesner MD | None | None | None | None | 06/14/2022 |
Andrew Wolf MD | None | None | None | None | 06/09/2022 |
Matthew Yurgelun MD | Janssen Pharmaceutica Products, LP | UpToDate | None | Facing Our Risk of Cancer Empowered (FORCE) advocacy group | 04/29/2022 |